These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11691806)

  • 1. Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.
    Murono S; Raab-Traub N; Pagano JS
    Cancer Res; 2001 Nov; 61(21):7875-7. PubMed ID: 11691806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.
    Neyts J; Sadler R; De Clercq E; Raab-Traub N; Pagano JS
    Cancer Res; 1998 Feb; 58(3):384-8. PubMed ID: 9458076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.
    Wakisaka N; Yoshizaki T; Raab-Traub N; Pagano JS
    Int J Cancer; 2005 Sep; 116(4):640-5. PubMed ID: 15818619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
    Liekens S; Neyts J; De Clercq E; Verbeken E; Ribatti D; Presta M
    Cancer Res; 2001 Jul; 61(13):5057-64. PubMed ID: 11431341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting effects of cidofovir (HPMPC) on the growth of the human cervical carcinoma (SiHa) xenografts in athymic nude mice.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):533-9. PubMed ID: 10338156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor potential of acyclic nucleoside phosphonates.
    De Clercq E; Andrei G; Balzarini J; Hatse S; Liekens S; Naesens L; Neyts J; Snoeck R
    Nucleosides Nucleotides; 1999; 18(4-5):759-71. PubMed ID: 10432678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
    Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 9-(2-Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase.
    Hatse S; Schols D; De Clercq E; Balzarini J
    Cell Growth Differ; 1999 Jun; 10(6):435-46. PubMed ID: 10392905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) inhibits HIV-1 replication in epithelial cells, but not T-lymphocytes.
    Srinivas RV; Connely M; Fridland A
    Antiviral Res; 1997 Jun; 35(1):23-7. PubMed ID: 9224958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tea polyphenol inhibit on growth of human nasopharyngeal carcinoma cell and xenograft in nude mice].
    Feng GK; Xie BF; Liu ZC; Zhu XF; Ye YL
    Ai Zheng; 2002 Apr; 21(4):392-4. PubMed ID: 12452018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimitotic and teratogenic effects of acyclic nucleotide analogues 1-(S)-(3-hydroxy-2-phosphonomethoxyethyl)cytosine (HPMPC) and 9-(2-phosphonomethoxyethyl) adenine (PMEA).
    Bílá V; Otová B; Jelínek R; Sladká M; Mejsnarová B; Holý A; Kren V
    Folia Biol (Praha); 1993; 39(3):150-61. PubMed ID: 8157136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures.
    Dal Pozzo F; Andrei G; Holy A; Van Den Oord J; Scagliarini A; De Clercq E; Snoeck R
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4843-52. PubMed ID: 16304144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    Intervirology; 1997; 40(5-6):295-303. PubMed ID: 9675635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytostatic effects and mechanism of action of antiviral acyclic adenine nucleotide analogs in L1210 mouse leukemia cells.
    Veselý J; Merta A; Votruba I; Rosenberg I; Holý A
    Neoplasma; 1990; 37(2):105-10. PubMed ID: 2342627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.